Skincare company Obagi Medical has announced the release of the new Nu-Cil Eyelash Enhancing Serum.

According to the company, the serum contains biotin, proprietary liquid compound, sodium hyaluronate, hyaluronic acid and vitamin B5 to enrich the lashes. The product uses patented NouriFlex technology to target lashes during lashes’ growth phase.

In a 16-week double-blind clinical study of the product, 93% of participants said their eyelashes showed visible improvement, 89% said their eyelashes looked thicker and 89% of participants said they looked more densely packed.

Dr Laurence Dryer, executive vice-president of research and development at Obagi, said “Over time, the natural lash cycle can be altered by factors such as hormones, stress level, or just the ageing process. As a result, eyelashes can deteriorate and decrease in volume, density, condition and pigment. By delivering the right blend of ingredients, Nu-Cil Eyelash Enhancing Serum targets the anagen phase of the lash cycle to support overall improvement in the appearance of lashes in as little as eight weeks.”

SOURCEAesthetics Journal
Previous articleAlastin Skincare: Galderma announces launch in the UK and direct distribution and expansion in Canada
Next articleBOTOX® Cosmetic (onabotulinumtoxinA) Day is Back Like Never Before